Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Notable Analyst Rating Changes 10/23: (MDT) (DD) (GNTX) Upgraded; (GS) (EXC) (COH) Downgraded
-
Argus Upgrades Medtronic, Inc. (MDT) to Buy
-
Notable Analyst Rating Changes 03/09+: (CHL) (KSS) (AONE) Upgraded; (GMCR) (WCRX) (MDT) Downgraded
-
Argus Downgrades Medtronic, Inc. (MDT) to Sell
-
Argus Upgrades Medtronic, Inc. (MDT) to Hold
-
Notable Analyst Rating Changes 05/31: (GS) (NVDA) (TZOO) Upgraded; (GSK) (MDT) (TASR) Downgraded
-
Argus Downgrades Medtronic, Inc. (MDT) to Sell
-
Notable Analyst Rating Changes 08/09: SKH, MYL, BEE, PG Upgraded; PCS, MDT, PMC, CSA Downgraded
-
David Moenning’s Daily State of the Markets: 6/26

